Pfizer said a mid-stage study of its investigational CDK4 inhibitor atirmociclib met its key goal in certain patients with breast cancer. Pfizer on Tuesday said the randomized Phase 2 study met its ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

ARLINGTON, Va.--(BUSINESS WIRE)--Today, Venture Global, Inc. (NYSE: VG) is announcing a final investment decision (FID) and successful closing of an $8.6 billion project financing for the second phase ...

The biggest stories of the day delivered to your inbox.

a By BICR. b Defined as the proportion of pts with confirmed CR/PR, or who met SD criteria at least once after tx initiation at an interval of ≥5 wk. This is an ASCO Meeting Abstract from the 2026 ...

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...

The mailman parked in front of my house today and asked for me. I had no clue what it was all about. He had two packages from Hong Kong, and I just assumed my wife had ordered something as a surprise.

Analysts, investors and scientists are eager for Biogen’s 2026 BIIB080 readout. Even if successful, executives warn that there are many more steps before the Alzheimer’s therapy could reach the market ...

Patchy Mix’s long-anticipated run in the UFC has come to a quick close. ESPN reports that the promotion has released the fighter from its roster less than a year after his debut, ending a brief stint ...